Overview

GSK372475 Bioequivalence Study

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study is to show the new salt formulation of GSK372475 is equivalent to the old salt formulation of GSK372475.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline